PF-Atlas › Clinical Trials › NCT04878913
Retrospective Evaluation of Lung Pathology in Subjects With COVID-19
C21 · Not specified
Registry ID
NCT04878913
Phase
Not specified
Status
Completed
Drug / intervention
C21
Sponsor
Vicore Pharma AB
Start
2021-07-07
Enrollment
35
Locations
4
About this trial
Non-interventional, retrospective, multi-center, follow-up study evaluating the effect of C21 on lung pathology in subjects previously hospitalised with COVID-19 and enrolled in the VP-C21-006 trial.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT04878913 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.